Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters




Mäkitie Antti A., Agaimy Abbas, Almangush Alhadi

PublisherMDPI

2022

Cancers

CANCERS

CANCERS

5514

14

22

10

2072-6694

DOIhttps://doi.org/10.3390/cancers14225514

https://www.mdpi.com/2072-6694/14/22/5514

https://research.utu.fi/converis/portal/detail/Publication/177448031



Tumor-node-metastasis (TNM) staging system is the cornerstone for treatment planning
of head and neck squamous cell carcinoma (HNSCC). Many prognostic biomarkers have been
introduced as modifiers to further improve the TNM classification of HNSCC. Here, we provide an
overview on the use of the recent prognostic biomarkers, with a focus on histopathologic parameters,
in improving the risk stratification of HNSCC and their application in the next generation of HNSCC
staging systems.


Last updated on 2024-26-11 at 21:56